- Report
- February 2024
- 120 Pages
Asia Pacific
From €4760EUR$4,950USD£4,083GBP
- Report
- January 2024
- 200 Pages
Global
From €4808EUR$5,000USD£4,124GBP
- Report
- September 2021
- 53 Pages
Global
From €2885EUR$3,000USD£2,475GBP
- Report
- September 2020
- 94 Pages
From €2019EUR$2,100USD£1,732GBP
€2885EUR$3,000USD£2,475GBP
- Report
- September 2020
- 98 Pages
North America
From €2019EUR$2,100USD£1,732GBP
€2885EUR$3,000USD£2,475GBP
- Report
- September 2020
- 109 Pages
Europe
From €2019EUR$2,100USD£1,732GBP
€2885EUR$3,000USD£2,475GBP
- Report
- September 2020
- 105 Pages
Asia Pacific
From €2019EUR$2,100USD£1,732GBP
€2885EUR$3,000USD£2,475GBP
- Report
- September 2020
- 82 Pages
Middle East, Africa
From €2019EUR$2,100USD£1,732GBP
€2885EUR$3,000USD£2,475GBP
- Report
- September 2023
- 200 Pages
Global
From €2884EUR$2,999USD£2,474GBP
- Report
- February 2024
- 180 Pages
Global
From €5288EUR$5,499USD£4,536GBP
- Report
- April 2023
- 160 Pages
Global
From €5768EUR$5,999USD£4,948GBP
- Book
- January 2014
- 624 Pages
€1717EUR$1,913USD£1,525GBP
- Book
- July 2024
North America
Urticaria, also known as hives, is a type of allergic reaction that causes red, itchy welts on the skin. It is a common condition that affects up to 20% of people at some point in their lives. Urticaria is caused by an immune system response to an allergen, such as food, pollen, or medication. It is usually treated with antihistamines, which block the release of histamine, a chemical that causes the swelling and itching associated with the condition. In more severe cases, immunosuppressants may be prescribed to reduce the body's immune response.
The Urticaria market is a subset of the Allergy and Immunology market, which is focused on the diagnosis and treatment of allergic and immunological conditions. This market includes a range of products, such as antihistamines, immunosuppressants, and other medications, as well as diagnostic tests and treatments.
Companies in the Urticaria market include pharmaceutical companies such as Sanofi, Novartis, and GlaxoSmithKline, as well as biotechnology companies such as Regeneron and Allergan. Diagnostic companies such as Quest Diagnostics and LabCorp also offer tests and treatments for Urticaria. Show Less Read more